|
C5ORF22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.057640E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.785600E-01 |
| Normal-vs-Stage2 |
3.205000E-01 |
| Normal-vs-Stage3 |
5.625900E-02 |
| Normal-vs-Stage4 |
1.433250E-01 |
| Stage1-vs-Stage2 |
8.119600E-01 |
| Stage1-vs-Stage3 |
2.319000E-01 |
| Stage1-vs-Stage4 |
4.796800E-01 |
| Stage2-vs-Stage3 |
5.863200E-01 |
| Stage2-vs-Stage4 |
7.419400E-01 |
| Stage3-vs-Stage4 |
8.525200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.504500E-02 |
| Normal-vs-AfricanAmerican |
7.953200E-01 |
| Normal-vs-Asian |
6.688600E-01 |
| Caucasian-vs-AfricanAmerican |
3.783000E-01 |
| Caucasian-vs-Asian |
2.806800E-01 |
| AfricanAmerican-vs-Asian |
9.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.332410E-01 |
| Normal-vs-Female |
1.286970E-01 |
| Male-vs-Female |
7.933800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.302000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.463680E-02 |
| Normal-vs-Age(61-80Yrs) |
6.129000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.275800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.686100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.778000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.799800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.292360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.428200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.346220E-01 |
| Classical-VS-Follicular |
9.388600E-01 |
| Classical-VS-Other |
8.204500E-02 |
| Classical-VS-Normal |
3.505400E-01 |
| Tall-VS-Follicular |
1.268350E-01 |
| Tall-VS-Other |
2.620800E-01 |
| Tall-VS-Normal |
2.961500E-02 |
| Follicular-VS-Other |
1.322200E-01 |
| Follicular-VS-Normal |
4.527800E-01 |
| Other-VS-Normal |
2.072500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.863900E-02 |
| Normal-vs-N1 |
3.195400E-01 |
| N0-vs-N1 |
7.295400E-01 |
|
|
